Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Ethinyl estradiol; norgestimate - Generic Drug Details

« Back to Dashboard

What are the generic sources for ethinyl estradiol; norgestimate and what is the scope of patent protection?

Ethinyl estradiol; norgestimate
is the generic ingredient in eighteen branded drugs marketed by Barr, Novast Labs Ltd, Watson Labs, Lupin Ltd, Mylan Labs Ltd, Sandoz Inc, Vintage Pharms Llc, Glenmark Generics, Lupin Pharms, Janssen Pharms, Aurobindo Pharma Ltd, Glenmark Pharms, Amneal Pharms, Haupt Pharma, Oc Pharma, Barr Labs Inc, and Sandoz, and is included in thirty-three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ethinyl estradiol; norgestimate has forty-three patent family members in twenty-five countries.

There are twenty-six drug master file entries for ethinyl estradiol; norgestimate. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: ethinyl estradiol; norgestimate

Drug Master File Entries: see list26
Suppliers / Packagers: see list22
Clinical Trials: see list260
Drug Prices:see low prices
DailyMed Link:ethinyl estradiol; norgestimate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
ethinyl estradiol; norgestimate
TABLET;ORAL-28205588-001Apr 26, 2016ABRXNoNo► Subscribe► Subscribe
ethinyl estradiol; norgestimate
TABLET;ORAL-28075804-001Sep 25, 2002ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
ethinyl estradiol; norgestimate
TABLET;ORAL-28200538-001Apr 5, 2012ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
ethinyl estradiol; norgestimate
TABLET;ORAL-28205762-001Nov 4, 2016ABRXNoNo► Subscribe► Subscribe
Janssen Pharms
ethinyl estradiol; norgestimate
TABLET;ORAL-28021241-001Aug 22, 2002ABRXYesYes6,214,815*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus